We reply within one business dayGet my quote
Obesity: US-approved treatments and how Gulf families can access them
A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.
Reviewed by the Reserve Meds clinical operations team on 17 October 2026.
Obesity: the short answer
The US FDA has approved three medicines on this page for obesity, each for specific patients. Two of them are on at least one Gulf register we checked, so ask your hospital about local supply first. Otherwise the hospital can request a named-patient import. Reserve Meds is a digital health company. We do not diagnose or prescribe.
- US FDA-approved medicines on this page: Wegovy, Zepbound and Imcivree.
- Gulf registration (checked 17 October 2026): see each medicine below.
- Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital.
- Price: Quote on request.
What is obesity?
Obesity is a disease that means having too much body fat. An adult with a body mass index (BMI) of 30 or more is considered to have obesity, and a BMI of 40 or more is severe obesity. Obesity increases the risk of many other health problems, especially when extra fat is carried around the waist.[1]
Obesity develops over time when more calories are taken in than the body uses. Genes, eating habits, physical activity, some medicines and some medical conditions all play a role. Doctors review weight history, examine the patient, order tests for weight-related conditions and calculate BMI.[1]
Treatment starts with diet, physical activity and behavior change. In the US, some injectable medicines are approved for long-term weight management in adults, and one medicine is approved for rare genetic and hypothalamic forms of obesity.[2, 3, 4]
Obesity in the Gulf
A review of Global Health Observatory data found that overweight and obesity in Saudi Arabia kept rising from 1990 to 2019, reaching more than 60% of adults and 20% to 60% of children and adolescents.[5]
US FDA-approved medicines for obesity
Each medicine below is approved in the US for a specific group of patients. The wording summarizes the current US label. Your specialist decides whether any of them is right for the patient.
- Wegovy (semaglutide)
FDA-approved for long-term weight reduction in adults and children 12 years and older with obesity, and adults with overweight and at least one weight-related condition, together with diet and exercise. It also reduces the risk of major heart events in adults with heart disease and obesity or overweight. It is a weekly injection.[2]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, Turkey, India, Pakistan - Zepbound (tirzepatide)
FDA-approved for long-term weight reduction in adults with obesity, or overweight with at least one weight-related condition, together with diet and exercise, and moderate to severe obstructive sleep apnea in adults with obesity. It is a weekly injection.[3]
Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, Jordan, Turkey, India, Pakistan - Imcivree (setmelanotide)
FDA-approved for excess weight in patients with rare forms of obesity listed in the label, including Bardet-Biedl syndrome, certain genetic (POMC, PCSK1, LEPR) deficiencies and acquired hypothalamic obesity, at the ages given in the label. It is a daily injection.[4]
Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.[6, 7]
Country guides: Kuwait, Oman, Egypt, Lebanon, Turkey
How families in the Gulf can access these medicines
If the medicine is listed in your country. Ask your specialist and the hospital pharmacy about local supply first. A listing does not mean every hospital stocks the medicine, and another brand of the same medicine may also be registered, but local supply is usually the fastest route and you may not need us.
If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.[8, 9] Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.
Who does what
- Your treating specialist decides whether a medicine is right for the patient and writes the letter.
- The hospital checks local supply, files any import request, and gives the treatment safely.
- The national regulator decides whether to approve the import of a medicine that is not registered.
- The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
- Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.
Documents you will usually need
- A letter from the treating specialist with the diagnosis, past treatments and why the medicine is being considered
- Reports that confirm the diagnosis, such as laboratory, genetic, imaging or pathology results, translated into English where needed
- Recent clinic notes and a list of current medicines
- For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
- Proof of the US FDA approval and the US prescribing information (we can supply these)
We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.
What treatment costs
Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.
How Reserve Meds helps
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.
Ask us about treatment for obesity
Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.
Frequently asked questions
Is there an FDA-approved treatment for obesity?
Yes. The medicines on this page have US FDA approval for specific groups of patients: Wegovy, Zepbound and Imcivree. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.
Is Wegovy available in Saudi Arabia or the UAE?
Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register. A listing in Abu Dhabi does not show federal UAE status.
How can a family in the Gulf get Wegovy?
Ask the treating hospital about local supply first. If it is not available, the hospital can file a named-patient import request with the national regulator on your specialist's written request. Once approved, we arrange US supply to the hospital pharmacy.
How much does treatment cost?
Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.
Are weight-loss injections used without diet changes?
No. The US labels describe these medicines as used in combination with a reduced-calorie diet and increased physical activity.
What BMI counts as obesity?
MedlinePlus defines obesity in adults as a BMI of 30 or more and severe obesity as 40 or more.
Sources for the last two answers: [2, 3] [1]
Sources
Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.
- MedlinePlus (US National Library of Medicine): Obesity
- DailyMed (US National Library of Medicine): Wegovy (semaglutide) US prescribing information, version published 30 June 2026
- DailyMed (US National Library of Medicine): Zepbound (tirzepatide) US prescribing information, version published 2 September 2026
- DailyMed (US National Library of Medicine): Imcivree (setmelanotide) US prescribing information, version published 2 April 2026
- Almubark et al. Epidemiology of obesity and control interventions in Saudi Arabia. East Mediterr Health J 2023 (PubMed 38279867)
- SFDA: Drugs List, public register (all 9,173 entries checked by brand name on 17 October 2026)
- Department of Health Abu Dhabi: drug code list Drugs.xlsx (release 26 September 2026, effective 2 October 2026)
- SFDA: Special Access Program (SAP) guidance, version 1.0
- NHRA Bahrain: Circular No. (41) of 2020, procedures for importing non-registered medicines and pharmaceutical products
Related
- Type 2 diabetes
- MASH (formerly NASH)
- Named-patient access in the Gulf, explained
- Answers to common access questions
- Cross-border disclosures
- اقرأ هذه الصفحة بالعربية
This page is general health information, not medical advice. It does not replace a consultation with your doctor.